Correlation Between Kane Biotech and Pharming Group

Can any of the company-specific risk be diversified away by investing in both Kane Biotech and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kane Biotech and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kane Biotech and Pharming Group NV, you can compare the effects of market volatilities on Kane Biotech and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kane Biotech with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kane Biotech and Pharming Group.

Diversification Opportunities for Kane Biotech and Pharming Group

0.35

Correlation Coefficient

Kane Biotech  Pharming Group

Weak diversification

The 3 months correlation between Kane and Pharming is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kane Biotech and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and Kane Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kane Biotech are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of Kane Biotech i.e., Kane Biotech and Pharming Group go up and down completely randomly.

Pair Corralation between Kane Biotech and Pharming Group

Assuming the 90 days horizon Kane Biotech is expected to generate 1.13 times more return on investment than Pharming Group. However, Kane Biotech is 1.13 times more volatile than Pharming Group NV. It trades about -0.01 of its potential returns per unit of risk. Pharming Group NV is currently generating about -0.04 per unit of risk. If you would invest  6.99  in Kane Biotech on December 28, 2024 and sell it today you would lose (0.29) from holding Kane Biotech or give up 4.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.39%
Values	Daily Returns

Kane Biotech  vs.  Pharming Group NV

Kane Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Kane Biotech is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pharming Group NV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharming Group NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Kane Biotech and Pharming Group

The main advantage of trading using opposite Kane Biotech and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kane Biotech position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.

The idea behind Kane Biotech and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.